Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


We live in a culture that venerates the new: new fashions, new cars, new movies—and new “miracle” drugs. But like new cars that exhibit glitches leading to recalls, new drugs may have unexpected side effects.

Consider the now infamous diet-drug combination fen-phen (fenfluramine and phentermine). The drugs themselves were not new, but the combination was hailed as a “breakthrough” in 1992 when doctors began prescribing it regularly. After more than 6 million prescriptions had been written, the duo was found to cause heart valve damage.

Before gaining approval, new drugs must be tested in both lab animals and humans. But those tests often create little more than the illusion of safety. The FDA may approve a new drug based on studies that show benefits without significant side effects in 2,000 rats and 200 humans. But the drug may cause serious problems in one of every 5,000 users. It would take several years for enough people to experience the problem and to connect it to the drug. A General Accounting Office review of 198 of the 209 new drugs approved from 1976 to 1985 found that 52 percent had “serious postapproval risks.”

Of course, if you have a life-threatening illness, the benefits of new drugs outweigh the risks. But for less grave conditions, think twice before taking new drugs.—M.C.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate